Article

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort

2023-06-06

Abstract excerpt

<title>Abstract</title> <p>Alzheimer's disease (AD) is a neurodegenerative disease that commonly causes dementia. Identifying biomarkers for the early detection of AD is an emerging need, as brain dysfunction begins two decades before the onset of clinical symptoms. To this end, we reanalyzed untargeted metabolomic mass spectrometry data from 960 patients enrolled in the AD Neuroimaging Initiative (ADNI) cohort u...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9af170c0-41b2-5dfc-8377-9088c09629d4
DOI: 10.21203/rs.3.rs-2973576/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortDOI 10.21203/rs.3.rs-2973576/v1Read

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortSemantic proximity Read

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brainsSemantic proximity Read

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.Semantic proximity Read

A seven-year longitudinal study of the Alzheimer’s disease blood metabolomeSemantic proximity Read

Differences in Plasma Metabolites Related to Alzheimer’s Disease, APOE-ε4 status and EthnicitySemantic proximity Read

Alteration of Metabolic Profile During the Progression of Alzheimer’s DiseaseSemantic proximity Read

The blood metabolome of cognitive function and brain health in middle-aged adults – influences of genes, gut microbiome, and exposomeSemantic proximity Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's diseaseSemantic proximity Read

Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participantsSemantic proximity Read

Sex Differences in the Metabolome of Alzheimer's Disease ProgressionSemantic proximity Read

Risk of Alzheimer's disease and genetically predicted levels of 1400 plasma metabolites: a Mendelian randomization study.Semantic proximity Read